These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Author: Dimroth H.
    Journal: Med Klin; 1979 Jun 01; 74(22):875-6. PubMed ID: 470785.
    Abstract:
    Etofibrate retard administered in a daily dose 500 mg to 14 outpatients with hyperlipoproteinemia type IIa decreased the cholesterol only 1.7% after a treatment period of 6 weeks. After a treatment of 12 weeks the serum cholesterol was higher in 10 of the 14 patients than in the pretreatment period. Of low grade was the effect of etofibrate retard in 6 patients with type IIb or IV. The triglycerides decreased from 564 mg/dl to 455 mg/dl in the mean. The effect of this double ester from clofibrinic and nicotinic acid (59% to 41%) is uncertain in HLP type IIa, IIb and IV in the recommended dose of 500 mg/day.
    [Abstract] [Full Text] [Related] [New Search]